SITAGLIPTIN

SITAGLIPTIN was reported 72453 times

SITAGLIPTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROLOGIC NEGLECT SYNDROME 281 0.5054
1 LUNG DIFFUSION TEST ABNORMAL 46 0.4742
2 BILE DUCT STENT INSERTION 146 0.3822
3 CAROTID ARTERY THROMBOSIS 289 0.3404
4 PNEUMOBILIA 39 0.2349
5 ADJUSTMENT DISORDER 282 0.2169
6 PANCREATICODUODENECTOMY 137 0.2063
7 ADENOCARCINOMA PANCREAS 250 0.1946
8 PANCREATIC CARCINOMA METASTATIC 531 0.1865
9 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 47 0.1521
10 PANCREATECTOMY 71 0.1272
11 PERSONALITY DISORDER 304 0.1159
12 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 39 0.1026
13 MULTIPLE DRUG THERAPY 61 0.0809
14 CARDIOSPASM 43 0.0771
15 PRODUCT MONITORING ERROR 98 0.0678
16 PANCREATIC MASS 72 0.0673
17 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 77 0.0643
18 EUGLYCAEMIC DIABETIC KETOACIDOSIS 258 0.0624
19 PALMOPLANTAR KERATODERMA 45 0.0621
20 DIABETES MELLITUS INADEQUATE CONTROL 1087 0.0613
21 PANCREATITIS CHRONIC 138 0.0582
22 PANCREATIC CARCINOMA 1670 0.0578
23 RADIOTHERAPY 103 0.0538
24 BLADDER TRANSITIONAL CELL CARCINOMA 76 0.0530
25 NEPHROGENIC ANAEMIA 242 0.0522
26 SPLENECTOMY 59 0.0508
27 ANAEMIA OF CHRONIC DISEASE 44 0.0487
28 ADRENAL MASS 40 0.0482
29 SERONEGATIVE ARTHRITIS 54 0.0471
30 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 49 0.0461
31 BILE DUCT STENOSIS 54 0.0450
32 GANGRENE 263 0.0436
33 PEMPHIGOID 319 0.0422
34 PANCREATITIS 2231 0.0422
35 ESSENTIAL HYPERTENSION 77 0.0420
36 HYPERPARATHYROIDISM SECONDARY 103 0.0411
37 GLYCOSYLATED HAEMOGLOBIN DECREASED 66 0.0410
38 GLYCOSYLATED HAEMOGLOBIN INCREASED 1032 0.0408
39 AORTIC ARTERIOSCLEROSIS 105 0.0408
40 HEMIPLEGIA 338 0.0406
41 BLADDER CANCER RECURRENT 40 0.0401
42 PANCREATIC CYST 73 0.0382
43 SENSORY LOSS 306 0.0380
44 BILE DUCT OBSTRUCTION 71 0.0374
45 DIABETIC METABOLIC DECOMPENSATION 51 0.0367
46 DIABETIC COMPLICATION 91 0.0357
47 DIABETIC NEUROPATHY 175 0.0353
48 BLOOD GLUCOSE ABNORMAL 652 0.0353
49 DIABETIC NEPHROPATHY 76 0.0345
50 TONSILLECTOMY 56 0.0335
51 HYPOGLYCAEMIA 1612 0.0332
52 LIPASE INCREASED 252 0.0329
53 METASTASES TO PERITONEUM 83 0.0328
54 PANCREATIC NEOPLASM 40 0.0323
55 ARTERIAL OCCLUSIVE DISEASE 253 0.0322
56 AFFECT LABILITY 306 0.0318
57 BLOOD GLUCOSE FLUCTUATION 339 0.0309
58 GASTROINTESTINAL HYPOMOTILITY 69 0.0306
59 KETOACIDOSIS 220 0.0294
60 RENAL CYST 233 0.0293
61 PANCREATITIS ACUTE 657 0.0292
62 BLOOD PRESSURE DIASTOLIC ABNORMAL 74 0.0291
63 MOTOR DYSFUNCTION 296 0.0290
64 PRURITUS GENITAL 68 0.0289
65 URINE KETONE BODY PRESENT 45 0.0285
66 DIVERTICULUM INTESTINAL 124 0.0283
67 PANCREATITIS NECROTISING 63 0.0274
68 BILIARY DILATATION 40 0.0272
69 METASTASES TO LIVER 478 0.0272
70 HYPOGLYCAEMIC COMA 78 0.0270
71 JOINT NOISE 53 0.0270
72 REBOUND ACID HYPERSECRETION 81 0.0268
73 ATRIAL TACHYCARDIA 55 0.0262
74 INABILITY TO AFFORD MEDICATION 258 0.0260
75 METASTASES TO LYMPH NODES 175 0.0259
76 SYSTEMIC INFECTION 42 0.0253
77 MUSCLE SPASTICITY 307 0.0250
78 HYPERLIPIDAEMIA 298 0.0249
79 LACTIC ACIDOSIS 802 0.0247
80 DIABETIC KETOACIDOSIS 587 0.0244
81 BLOOD GLUCOSE INCREASED 4520 0.0240
82 DIABETIC RETINOPATHY 81 0.0238
83 AMYLASE INCREASED 88 0.0238
84 DYSLIPIDAEMIA 119 0.0234
85 MEDICATION RESIDUE 60 0.0233
86 IMPAIRED GASTRIC EMPTYING 306 0.0224
87 COORDINATION ABNORMAL 308 0.0221
88 DIVERTICULUM 156 0.0219
89 PERIPHERAL VASCULAR DISORDER 112 0.0217
90 PROSTATOMEGALY 85 0.0216
91 HYPERLACTACIDAEMIA 58 0.0216
92 MICTURITION DISORDER 73 0.0210
93 HAEMORRHAGIC ANAEMIA 92 0.0209
94 JAUNDICE CHOLESTATIC 73 0.0206
95 HEMIPARESIS 350 0.0206
96 SINUS CONGESTION 272 0.0201
97 EXERCISE TOLERANCE DECREASED 111 0.0193
98 GASTROINTESTINAL TUBE INSERTION 48 0.0192
99 RENAL MASS 39 0.0189
100 BLOOD GLUCOSE DECREASED 885 0.0184
101 BENIGN PROSTATIC HYPERPLASIA 95 0.0184
102 SPINAL OSTEOARTHRITIS 160 0.0182
103 CAROTID ARTERY OCCLUSION 66 0.0181
104 END STAGE RENAL DISEASE 329 0.0180
105 ARTERIOSCLEROSIS CORONARY ARTERY 117 0.0176
106 HYPERGLYCAEMIA 643 0.0176
107 BLOOD PRESSURE INADEQUATELY CONTROLLED 106 0.0176
108 HYPERKALAEMIA 604 0.0172
109 APPENDICECTOMY 61 0.0171
110 BLOOD PRESSURE SYSTOLIC ABNORMAL 42 0.0170
111 ATELECTASIS 164 0.0170
112 EATING DISORDER 361 0.0169
113 SKIN HAEMORRHAGE 244 0.0164
114 HEPATIC CYST 55 0.0162
115 LARGE INTESTINE POLYP 112 0.0162
116 NEPHROPATHY 150 0.0160
117 PANCREATIC DISORDER 79 0.0160
118 METASTASES TO LUNG 183 0.0158
119 PHARYNGOLARYNGEAL PAIN 84 0.0158
120 POTENTIATING DRUG INTERACTION 53 0.0158
121 SINUS DISORDER 311 0.0157
122 CHRONIC KIDNEY DISEASE 1187 0.0156
123 HYPOMAGNESAEMIA 216 0.0155
124 LIPOMA 40 0.0154
125 RESPIRATORY TRACT CONGESTION 245 0.0154
126 HAEMOGLOBIN INCREASED 70 0.0153
127 DUODENITIS 47 0.0153
128 LEG AMPUTATION 63 0.0153
129 HEPATIC LESION 65 0.0150
130 ACUTE KIDNEY INJURY 2283 0.0149
131 CHOLECYSTECTOMY 170 0.0149
132 HYPOVOLAEMIA 86 0.0147
133 METABOLIC ACIDOSIS 467 0.0146
134 FULL BLOOD COUNT ABNORMAL 150 0.0142
135 BILE DUCT STONE 45 0.0141
136 UROSEPSIS 130 0.0141
137 HYPERCHOLESTEROLAEMIA 136 0.0141
138 CATARACT OPERATION 83 0.0140
139 NORMOCHROMIC NORMOCYTIC ANAEMIA 42 0.0140
140 ANGINA PECTORIS 396 0.0138
141 CAROTID ARTERY STENOSIS 48 0.0137
142 MEDICATION RESIDUE PRESENT 64 0.0134
143 TOE AMPUTATION 68 0.0134
144 PEPTIC ULCER 44 0.0132
145 PULMONARY MASS 194 0.0130
146 HEPATIC STEATOSIS 242 0.0130
147 GOITRE 53 0.0129
148 STENT PLACEMENT 103 0.0128
149 NECROTISING FASCIITIS 45 0.0128
150 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 52 0.0127
151 ABNORMAL LOSS OF WEIGHT 86 0.0126
152 HIATUS HERNIA 163 0.0126
153 ORTHOPNOEA 40 0.0125
154 SNEEZING 281 0.0125
155 APHASIA 378 0.0125
156 CARDIAC FAILURE CHRONIC 53 0.0124
157 BLADDER CANCER 732 0.0124
158 TENSION HEADACHE 53 0.0123
159 ARTERIOSCLEROSIS 116 0.0123
160 CORONARY ARTERY BYPASS 70 0.0122
161 TUBULOINTERSTITIAL NEPHRITIS 227 0.0121
162 AORTIC STENOSIS 42 0.0120
163 CHOLELITHIASIS 395 0.0120
164 UMBILICAL HERNIA 56 0.0120
165 POLYURIA 98 0.0120
166 CYSTITIS 379 0.0119
167 GLOMERULAR FILTRATION RATE DECREASED 146 0.0119
168 BLOOD PRESSURE SYSTOLIC INCREASED 231 0.0118
169 TYPE 1 DIABETES MELLITUS 71 0.0118
170 DYSARTHRIA 442 0.0117
171 VITAMIN D DEFICIENCY 114 0.0117
172 SCOLIOSIS 72 0.0116
173 VITAMIN B12 DEFICIENCY 47 0.0116
174 IRON DEFICIENCY ANAEMIA 107 0.0116
175 HYPOVOLAEMIC SHOCK 55 0.0115
176 SLEEP APNOEA SYNDROME 219 0.0115
177 TYPE 2 DIABETES MELLITUS 386 0.0115
178 RALES 66 0.0114
179 RETINOPATHY 42 0.0112
180 WRONG TECHNIQUE IN DRUG USAGE PROCESS 405 0.0111
181 RHINORRHOEA 720 0.0111
182 ACIDOSIS 85 0.0111
183 RENAL TUBULAR NECROSIS 109 0.0111
184 ELECTROLYTE IMBALANCE 129 0.0111
185 ELECTROCARDIOGRAM ABNORMAL 87 0.0111
186 UPPER GASTROINTESTINAL HAEMORRHAGE 186 0.0110
187 RENAL FAILURE 1468 0.0110
188 STOMACH DISCOMFORT 57 0.0110
189 LEFT VENTRICULAR DYSFUNCTION 73 0.0109
190 BLOOD LACTIC ACID INCREASED 57 0.0108
191 CHOLANGITIS 67 0.0108
192 POLYDIPSIA 42 0.0106
193 GOUT 188 0.0105
194 SLEEP TERROR 44 0.0104
195 DIABETES MELLITUS 793 0.0104
196 BRONCHIECTASIS 70 0.0104
197 ABDOMINAL HERNIA 47 0.0103
198 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 91 0.0103
199 BLOOD PRESSURE DIASTOLIC INCREASED 47 0.0102
200 ATRIOVENTRICULAR BLOCK FIRST DEGREE 44 0.0101
201 HYSTERECTOMY 87 0.0100
202 RENAL FAILURE CHRONIC 77 0.0100
203 ROTATOR CUFF SYNDROME 128 0.0100
204 SUBCUTANEOUS ABSCESS 47 0.0098
205 OBSTRUCTIVE AIRWAYS DISORDER 109 0.0098
206 OSTEOARTHRITIS 415 0.0098
207 BLOOD CHOLESTEROL ABNORMAL 45 0.0097
208 BLOOD CREATINE INCREASED 43 0.0097
209 RENAL FUNCTION TEST ABNORMAL 45 0.0097
210 DRUG LEVEL ABOVE THERAPEUTIC 44 0.0096
211 LOWER GASTROINTESTINAL HAEMORRHAGE 71 0.0096
212 HYPOKINESIA 139 0.0096
213 GENERALISED OEDEMA 118 0.0095
214 SPINAL COLUMN STENOSIS 45 0.0095
215 CEREBRAL INFARCTION 232 0.0095
216 BLOOD POTASSIUM INCREASED 154 0.0095
217 BLOOD PRESSURE DIASTOLIC DECREASED 70 0.0095
218 CARDIAC MURMUR 82 0.0095
219 CORONARY ARTERY DISEASE 286 0.0094
220 CATARACT 559 0.0094
221 INJECTION SITE NODULE 103 0.0094
222 ACUTE RESPIRATORY FAILURE 179 0.0093
223 INTERVERTEBRAL DISC DEGENERATION 86 0.0093
224 INTERSTITIAL LUNG DISEASE 449 0.0093
225 GASTRITIS EROSIVE 43 0.0092
226 MALNUTRITION 103 0.0092
227 GASTROOESOPHAGEAL REFLUX DISEASE 741 0.0092
228 BUNDLE BRANCH BLOCK LEFT 39 0.0092
229 MYOPATHY 79 0.0091
230 PYELONEPHRITIS 79 0.0091
231 BLOOD UREA INCREASED 152 0.0091
232 ANURIA 78 0.0091
233 BLOOD PRESSURE SYSTOLIC DECREASED 41 0.0090
234 ILEUS 112 0.0090
235 CHOLECYSTITIS 107 0.0090
236 LEUKOCYTOSIS 162 0.0089
237 BLOOD CREATININE INCREASED 584 0.0089
238 CORONARY ARTERIAL STENT INSERTION 45 0.0089
239 RENAL IMPAIRMENT 745 0.0089
240 HYPERNATRAEMIA 44 0.0088
241 ACUTE MYOCARDIAL INFARCTION 260 0.0088
242 HYDRONEPHROSIS 66 0.0088
243 DUODENAL ULCER 62 0.0088
244 NEPHROLITHIASIS 402 0.0088
245 BURSITIS 106 0.0087
246 RENAL DISORDER 406 0.0087
247 HYPERTRIGLYCERIDAEMIA 51 0.0087
248 CARDIAC FAILURE ACUTE 58 0.0087
249 OEDEMA PERIPHERAL 1061 0.0087
250 CARDIOMEGALY 107 0.0087
251 BLOOD MAGNESIUM DECREASED 75 0.0087
252 NERVE COMPRESSION 80 0.0087
253 CHOLECYSTITIS ACUTE 49 0.0086
254 HYPOTHYROIDISM 276 0.0086
255 NEPHROTIC SYNDROME 59 0.0086
256 ASCITES 252 0.0086
257 CORONARY ARTERY STENOSIS 43 0.0085
258 INGUINAL HERNIA 52 0.0085
259 BLOOD TRIGLYCERIDES INCREASED 151 0.0085
260 SPLENOMEGALY 100 0.0085
261 DYSPHAGIA 809 0.0085
262 RHABDOMYOLYSIS 355 0.0085
263 DEHYDRATION 1124 0.0084
264 RENAL FAILURE ACUTE 356 0.0084
265 CARDIAC PACEMAKER INSERTION 50 0.0084
266 PRODUCT DOSE OMISSION 545 0.0083
267 SUBARACHNOID HAEMORRHAGE 85 0.0083
268 MELAENA 183 0.0083
269 OBESITY 132 0.0083
270 FACIAL PAIN 73 0.0082
271 DYSURIA 298 0.0081
272 MUSCLE ATROPHY 102 0.0080
273 FAECALOMA 44 0.0080
274 GALLBLADDER DISORDER 143 0.0080
275 HAEMORRHOIDAL HAEMORRHAGE 39 0.0080
276 ACUTE CORONARY SYNDROME 66 0.0080
277 POLLAKIURIA 332 0.0080
278 GAMMA-GLUTAMYLTRANSFERASE INCREASED 175 0.0079
279 MUSCULAR WEAKNESS 897 0.0079
280 INTERNAL HAEMORRHAGE 90 0.0079
281 RENAL INJURY 233 0.0078
282 HEPATIC CIRRHOSIS 146 0.0078
283 RENAL PAIN 82 0.0077
284 ARTHRITIS 601 0.0076
285 BLOOD URIC ACID INCREASED 44 0.0076
286 GASTRIC ULCER HAEMORRHAGE 42 0.0076
287 THIRST 135 0.0075
288 ANGINA UNSTABLE 49 0.0075
289 GENERAL PHYSICAL HEALTH DETERIORATION 870 0.0075
290 FAILURE TO THRIVE 39 0.0075
291 NOCTURIA 91 0.0075
292 SHOCK HAEMORRHAGIC 61 0.0075
293 INJECTION SITE EXTRAVASATION 92 0.0074
294 HYPONATRAEMIA 419 0.0074
295 PRODUCT RESIDUE PRESENT 40 0.0074
296 ATRIAL FLUTTER 59 0.0074
297 DRUG ERUPTION 131 0.0074
298 GASTROINTESTINAL DISORDER 661 0.0074
299 ANAEMIA 1400 0.0073
300 MACULAR OEDEMA 41 0.0073
301 UPPER RESPIRATORY TRACT INFECTION 335 0.0072
302 OLIGURIA 45 0.0072
303 GINGIVITIS 39 0.0072
304 CORONARY ARTERY OCCLUSION 99 0.0072
305 URINE OUTPUT DECREASED 63 0.0072
306 PROTEINURIA 137 0.0072
307 SEPTIC SHOCK 312 0.0072
308 ANGIOEDEMA 317 0.0072
309 METASTASIS 51 0.0071
310 CARDIOMYOPATHY 105 0.0071
311 CARDIAC FAILURE CONGESTIVE 570 0.0071
312 DIVERTICULITIS 196 0.0071
313 HEPATIC ENCEPHALOPATHY 66 0.0071
314 HYPOKALAEMIA 325 0.0070
315 EMPHYSEMA 71 0.0070
316 GASTRITIS 185 0.0070
317 MUSCULOSKELETAL PAIN 368 0.0070
318 ATRIOVENTRICULAR BLOCK COMPLETE 47 0.0070
319 WEIGHT DECREASED 1950 0.0070
320 JOINT EFFUSION 48 0.0070
321 FLANK PAIN 65 0.0069
322 HYPOCALCAEMIA 131 0.0069
323 CONSTIPATION 1508 0.0069
324 ADVERSE EVENT 634 0.0069
325 ALTERED STATE OF CONSCIOUSNESS 149 0.0069
326 CHOLECYSTITIS CHRONIC 46 0.0069
327 ATRIOVENTRICULAR BLOCK 53 0.0068
328 ATRIAL FIBRILLATION 667 0.0068
329 BLOOD THYROID STIMULATING HORMONE INCREASED 63 0.0068
330 HYPOPHAGIA 175 0.0068
331 VENTRICULAR TACHYCARDIA 113 0.0068
332 HAEMATURIA 234 0.0068
333 HYPERTHERMIA 52 0.0068
334 MUSCULOSKELETAL CHEST PAIN 105 0.0068
335 HYPOPHOSPHATAEMIA 50 0.0068
336 ADRENAL INSUFFICIENCY 82 0.0068
337 BLOOD POTASSIUM DECREASED 203 0.0067
338 HUNGER 94 0.0067
339 CARDIAC FAILURE 540 0.0067
340 FUNGAL INFECTION 224 0.0067
341 ERUCTATION 130 0.0067
342 METABOLIC DISORDER 39 0.0067
343 TROPONIN INCREASED 51 0.0067
344 URINARY TRACT INFECTION 1140 0.0067
345 NO ADVERSE EVENT 1208 0.0067
346 COAGULOPATHY 111 0.0067
347 OEDEMA 360 0.0066
348 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 345 0.0066
349 VASCULITIS 77 0.0066
350 EOSINOPHIL COUNT INCREASED 55 0.0066
351 COLON CANCER 98 0.0066
352 HAEMORRHOIDS 128 0.0066
353 HAEMATOMA 170 0.0066
354 DYSPNOEA EXERTIONAL 247 0.0066
355 CARDIOGENIC SHOCK 94 0.0065
356 TRANSIENT ISCHAEMIC ATTACK 221 0.0065
357 INTERVERTEBRAL DISC PROTRUSION 143 0.0065
358 JAUNDICE 175 0.0065
359 TACHYPNOEA 88 0.0065
360 GASTRIC ULCER 123 0.0065
361 EOSINOPHILIA 113 0.0064
362 BLADDER DISORDER 64 0.0064
363 DIALYSIS 91 0.0064
364 SKIN ULCER 165 0.0064
365 CONFUSIONAL STATE 1031 0.0064
366 HYPERBILIRUBINAEMIA 66 0.0064
367 LIP SWELLING 212 0.0064
368 MITRAL VALVE INCOMPETENCE 72 0.0064
369 HAEMATOCHEZIA 351 0.0064
370 CORONAVIRUS INFECTION 42 0.0063
371 GASTROINTESTINAL HAEMORRHAGE 530 0.0063
372 SWOLLEN TONGUE 198 0.0063
373 BLOOD PRESSURE INCREASED 969 0.0063
374 ANAL INCONTINENCE 57 0.0063
375 HYPERTENSION 1339 0.0063
376 FLATULENCE 358 0.0063
377 GASTRIC DISORDER 216 0.0063
378 CEREBROVASCULAR ACCIDENT 1066 0.0063
379 GLAUCOMA 121 0.0063
380 ABDOMINAL PAIN 1461 0.0063
381 BLOOD PRESSURE ABNORMAL 124 0.0062
382 HYPERCALCAEMIA 77 0.0062
383 CELLULITIS 314 0.0062
384 ULCER 99 0.0062
385 POSTOPERATIVE WOUND INFECTION 42 0.0062
386 CARPAL TUNNEL SYNDROME 87 0.0062
387 PERIPHERAL COLDNESS 85 0.0062
388 FAECES DISCOLOURED 134 0.0062
389 INCREASED APPETITE 118 0.0062
390 PHARYNGEAL OEDEMA 95 0.0062
391 TRICUSPID VALVE INCOMPETENCE 49 0.0062
392 THYROID CANCER 74 0.0061
393 DECREASED APPETITE 1424 0.0061
394 PRODUCT PRESCRIBING ERROR 146 0.0061
395 MULTIPLE ALLERGIES 48 0.0061
396 LOCALISED INFECTION 148 0.0061
397 ASPIRATION 67 0.0061
398 WEIGHT FLUCTUATION 64 0.0061
399 PLEURAL EFFUSION 372 0.0061
400 BLOOD CREATINE PHOSPHOKINASE INCREASED 175 0.0061
401 DERMATITIS BULLOUS 44 0.0061
402 HEPATOCELLULAR CARCINOMA 46 0.0060
403 BLOOD SODIUM DECREASED 114 0.0060
404 DYSPEPSIA 595 0.0060
405 AORTIC ANEURYSM 46 0.0060
406 PALPITATIONS 708 0.0060
407 CLOSTRIDIUM DIFFICILE COLITIS 64 0.0060
408 APPETITE DISORDER 40 0.0060
409 ORTHOSTATIC HYPOTENSION 105 0.0060
410 DECUBITUS ULCER 49 0.0060
411 BLOOD PRESSURE FLUCTUATION 144 0.0060
412 KNEE OPERATION 59 0.0060
413 HAEMATEMESIS 152 0.0060
414 GASTROENTERITIS 87 0.0060
415 HELICOBACTER INFECTION 61 0.0059
416 BLOOD ALKALINE PHOSPHATASE INCREASED 147 0.0059
417 RASH GENERALISED 153 0.0059
418 SHOCK 135 0.0059
419 NEUTROPHIL COUNT INCREASED 60 0.0059
420 ECONOMIC PROBLEM 88 0.0058
421 HAEMATOCRIT DECREASED 115 0.0058
422 BLOOD URINE PRESENT 110 0.0058
423 CHOLESTASIS 111 0.0058
424 ABDOMINAL PAIN UPPER 1189 0.0058
425 HAEMORRHAGIC STROKE 45 0.0058
426 RETINAL HAEMORRHAGE 41 0.0058
427 TENDONITIS 89 0.0057
428 RASH PRURITIC 311 0.0057
429 ISCHAEMIC STROKE 102 0.0057
430 ASTHENIA 2146 0.0057
431 HEPATIC FUNCTION ABNORMAL 213 0.0057
432 PULMONARY CONGESTION 75 0.0057
433 INCONTINENCE 60 0.0057
434 PNEUMONIA BACTERIAL 52 0.0057
435 SUBDURAL HAEMATOMA 81 0.0057
436 FAECES SOFT 41 0.0056
437 URINARY INCONTINENCE 167 0.0056
438 NASAL CONGESTION 331 0.0056
439 DIARRHOEA 3631 0.0056
440 FALL 1872 0.0056
441 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 95 0.0056
442 PRODUCT DOSE OMISSION ISSUE 1643 0.0056
443 FLUID RETENTION 284 0.0056
444 INTERNATIONAL NORMALISED RATIO INCREASED 159 0.0056
445 UPPER LIMB FRACTURE 111 0.0056
446 BLOOD IRON DECREASED 66 0.0056
447 SINUSITIS 570 0.0056
448 DRUG INTERACTION 881 0.0055
449 FURUNCLE 44 0.0055
450 PNEUMONIA 1797 0.0055
451 CHEST DISCOMFORT 568 0.0055
452 LIVER FUNCTION TEST ABNORMAL 161 0.0055
453 HYPOALBUMINAEMIA 43 0.0055
454 DEMENTIA 154 0.0055
455 FEELING JITTERY 105 0.0055
456 DELIRIUM 191 0.0055
457 SINUS TACHYCARDIA 78 0.0055
458 FOOT FRACTURE 104 0.0055
459 DISSEMINATED INTRAVASCULAR COAGULATION 77 0.0055
460 ERYTHEMA MULTIFORME 51 0.0055
461 CARDIAC OPERATION 47 0.0055
462 SPINAL PAIN 64 0.0055
463 MOUTH HAEMORRHAGE 40 0.0055
464 LYMPHADENOPATHY 193 0.0054
465 INFLUENZA 606 0.0054
466 METASTASES TO BONE 89 0.0054
467 WHEEZING 320 0.0054
468 RED BLOOD CELL COUNT DECREASED 154 0.0054
469 VITAMIN D DECREASED 46 0.0054
470 PULMONARY FIBROSIS 103 0.0054
471 HICCUPS 44 0.0054
472 MYOCARDIAL ISCHAEMIA 61 0.0054
473 OSTEOPOROSIS 220 0.0053
474 TRANSFUSION 56 0.0053
475 LOCAL SWELLING 93 0.0053
476 RETINAL DETACHMENT 49 0.0053
477 EYE HAEMORRHAGE 71 0.0053
478 CYST 66 0.0053
479 URINARY RETENTION 177 0.0053
480 TREATMENT NONCOMPLIANCE 290 0.0053
481 DISORIENTATION 210 0.0053
482 PNEUMONIA ASPIRATION 132 0.0053
483 BODY TEMPERATURE DECREASED 52 0.0053
484 PRURITUS GENERALISED 114 0.0053
485 DIZZINESS POSTURAL 51 0.0053
486 PERIPHERAL SWELLING 810 0.0053
487 HAEMOLYTIC ANAEMIA 47 0.0052
488 VOMITING 2462 0.0052
489 SEPSIS 583 0.0052
490 RHEUMATOID ARTHRITIS 593 0.0052
491 HAIR DISORDER 43 0.0052
492 POOR QUALITY PRODUCT ADMINISTERED 55 0.0052
493 LIVER DISORDER 231 0.0052
494 BRADYCARDIA 276 0.0052
495 ABDOMINAL DISTENSION 541 0.0052
496 ABDOMINAL DISCOMFORT 867 0.0052
497 BACK DISORDER 84 0.0052
498 BACK PAIN 1200 0.0052
499 COUGH 1448 0.0052
500 MUSCLE TWITCHING 119 0.0052
501 PROSTATIC SPECIFIC ANTIGEN INCREASED 71 0.0051
502 MYALGIA 876 0.0051
503 DIPLOPIA 133 0.0051
504 SMALL INTESTINAL OBSTRUCTION 63 0.0051
505 HAND DEFORMITY 67 0.0051
506 NEUROPATHY PERIPHERAL 483 0.0051
507 ABSCESS 81 0.0051
508 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 360 0.0051
509 PULMONARY HYPERTENSION 105 0.0050
510 INFLUENZA LIKE ILLNESS 414 0.0050
511 DIZZINESS 2508 0.0050
512 SCIATICA 80 0.0050
513 SEASONAL ALLERGY 71 0.0050
514 COGNITIVE DISORDER 234 0.0050
515 NAUSEA 3964 0.0050
516 MYOCARDIAL INFARCTION 872 0.0050
517 EPISTAXIS 373 0.0050
518 PLATELET COUNT INCREASED 65 0.0050
519 TOXIC SKIN ERUPTION 50 0.0050
520 PRODUCT DISTRIBUTION ISSUE 46 0.0050
521 RECTAL HAEMORRHAGE 213 0.0050
522 DRUG LEVEL INCREASED 82 0.0049
523 PRODUCTIVE COUGH 236 0.0049
524 CIRCULATORY COLLAPSE 84 0.0049
525 HYPOTENSION 989 0.0049
526 FACIAL PARALYSIS 42 0.0049
527 C-REACTIVE PROTEIN INCREASED 179 0.0049
528 BLOOD ALBUMIN DECREASED 39 0.0049
529 ANOSMIA 71 0.0049
530 MYOSITIS 44 0.0049
531 INCREASED TENDENCY TO BRUISE 45 0.0049
532 PERICARDITIS 82 0.0049
533 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 50 0.0049
534 ORAL PAIN 109 0.0049
535 THYROID DISORDER 75 0.0049
536 OSTEOMYELITIS 88 0.0049
537 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 164 0.0049
538 PULMONARY ARTERIAL HYPERTENSION 70 0.0048
539 SUDDEN DEATH 51 0.0048
540 EXOSTOSIS 44 0.0048
541 VENTRICULAR EXTRASYSTOLES 50 0.0048
542 HEPATITIS 123 0.0048
543 BACTERAEMIA 57 0.0048
544 KIDNEY INFECTION 94 0.0048
545 NASOPHARYNGITIS 881 0.0048
546 SYNCOPE 478 0.0048
547 BONE DISORDER 87 0.0048
548 MACULAR DEGENERATION 57 0.0048
549 VENTRICULAR FIBRILLATION 53 0.0048
550 OESOPHAGITIS 52 0.0048
551 SKIN EXFOLIATION 401 0.0047
552 DRY THROAT 48 0.0047
553 CEREBRAL HAEMORRHAGE 169 0.0047
554 ERECTILE DYSFUNCTION 121 0.0047
555 SUPRAVENTRICULAR TACHYCARDIA 45 0.0047
556 BLOOD CHOLESTEROL INCREASED 219 0.0047
557 EJECTION FRACTION DECREASED 73 0.0047
558 HAEMOGLOBIN DECREASED 482 0.0047
559 HEPATOMEGALY 46 0.0047
560 MEDICATION ERROR 260 0.0047
561 RESTLESS LEGS SYNDROME 85 0.0047
562 NODULE 61 0.0047
563 FLUID OVERLOAD 68 0.0047
564 HYPERHIDROSIS 600 0.0047
565 PAIN IN EXTREMITY 1371 0.0046
566 RESPIRATORY TRACT INFECTION 121 0.0046
567 GASTROINTESTINAL PAIN 51 0.0046
568 IMPAIRED WORK ABILITY 99 0.0046
569 PALLOR 126 0.0046
570 MUSCLE STRAIN 40 0.0046
571 PANCYTOPENIA 258 0.0046
572 DRUG DOSE OMISSION 760 0.0046
573 WEIGHT INCREASED 1028 0.0046
574 HEPATOCELLULAR INJURY 65 0.0046
575 HYPERTENSIVE CRISIS 51 0.0046
576 HEART RATE INCREASED 453 0.0046
577 BLOOD CALCIUM INCREASED 40 0.0046
578 LIGAMENT SPRAIN 45 0.0045
579 PERICARDIAL EFFUSION 105 0.0045
580 PSYCHOLOGICAL TRAUMA 39 0.0045
581 RESPIRATORY DISORDER 135 0.0045
582 BRONCHITIS 334 0.0045
583 DRY MOUTH 366 0.0045
584 OROPHARYNGEAL PAIN 416 0.0045
585 OSTEOPENIA 68 0.0045
586 MALAISE 1964 0.0045
587 CHROMATURIA 101 0.0045
588 POOR QUALITY SLEEP 96 0.0045
589 INTESTINAL OBSTRUCTION 168 0.0045
590 CHEST PAIN 824 0.0044
591 LUNG DISORDER 218 0.0044
592 PULMONARY OEDEMA 199 0.0044
593 WOUND 124 0.0044
594 PHARYNGITIS 55 0.0044
595 OROPHARYNGEAL DISCOMFORT 40 0.0044
596 ASTHMA 500 0.0044
597 TACHYCARDIA 393 0.0044
598 PLATELET COUNT DECREASED 471 0.0044
599 RESPIRATORY FAILURE 322 0.0044
600 AGRANULOCYTOSIS 82 0.0044
601 BALANCE DISORDER 381 0.0044
602 HEPATIC CYTOLYSIS 56 0.0044
603 FRACTURE 83 0.0044
604 RIB FRACTURE 90 0.0044
605 DECREASED ACTIVITY 47 0.0044
606 BLOOD COUNT ABNORMAL 66 0.0043
607 ABDOMINAL PAIN LOWER 110 0.0043
608 PAIN OF SKIN 117 0.0043
609 NIGHT SWEATS 140 0.0043
610 OXYGEN SATURATION DECREASED 244 0.0043
611 BLOOD BILIRUBIN INCREASED 117 0.0043
612 SPUTUM DISCOLOURED 41 0.0043
613 COVID-19 PNEUMONIA 51 0.0043
614 SWELLING FACE 281 0.0043
615 TASTE DISORDER 87 0.0043
616 MENTAL STATUS CHANGES 119 0.0043
617 AMNESIA 278 0.0043
618 ARRHYTHMIA 202 0.0043
619 TOOTH FRACTURE 47 0.0043
620 HAIR COLOUR CHANGES 53 0.0043
621 VISUAL ACUITY REDUCED 141 0.0042
622 DYSPNOEA 2402 0.0042
623 ARTHRALGIA 1764 0.0042
624 FEEDING DISORDER 86 0.0042
625 ACCIDENTAL UNDERDOSE 61 0.0042
626 CARDIO-RESPIRATORY ARREST 177 0.0042
627 PARAESTHESIA ORAL 61 0.0042
628 APHONIA 59 0.0042
629 GASTROENTERITIS VIRAL 76 0.0042
630 COLD SWEAT 74 0.0042
631 HERPES ZOSTER 241 0.0042
632 VISION BLURRED 575 0.0042
633 LYMPHOCYTE COUNT DECREASED 74 0.0042
634 HEPATIC ENZYME INCREASED 284 0.0042
635 BLINDNESS 169 0.0041
636 WHITE BLOOD CELL COUNT INCREASED 159 0.0041
637 PRODUCT USE ISSUE 778 0.0041
638 LEUKAEMIA 39 0.0041
639 CONTUSION 397 0.0041
640 HEADACHE 2584 0.0041
641 HEART RATE DECREASED 144 0.0041
642 ANXIETY 1165 0.0041
643 AGEUSIA 102 0.0041
644 ALANINE AMINOTRANSFERASE INCREASED 251 0.0041
645 KNEE ARTHROPLASTY 86 0.0041
646 CARDIAC ARREST 337 0.0041
647 HEPATIC FAILURE 123 0.0041
648 DRUG-INDUCED LIVER INJURY 128 0.0041
649 PEMPHIGUS 51 0.0041
650 SCRATCH 43 0.0041
651 BLOOD PRESSURE DECREASED 270 0.0041
652 PHOTOSENSITIVITY REACTION 67 0.0041
653 EYE SWELLING 150 0.0040
654 CARDIAC DISORDER 376 0.0040
655 ANKLE FRACTURE 62 0.0040
656 MULTI-ORGAN FAILURE 69 0.0040
657 PSORIASIS 521 0.0040
658 HEART RATE IRREGULAR 90 0.0040
659 GAIT DISTURBANCE 759 0.0040
660 DRUG PRESCRIBING ERROR 76 0.0040
661 DEEP VEIN THROMBOSIS 257 0.0040
662 DEPRESSED MOOD 209 0.0039
663 BLISTER 222 0.0039
664 TOOTH INFECTION 52 0.0039
665 JOINT SWELLING 476 0.0039
666 TINNITUS 181 0.0039
667 MICTURITION URGENCY 45 0.0039
668 PYREXIA 1357 0.0039
669 HEAD INJURY 124 0.0039
670 IRRITABLE BOWEL SYNDROME 84 0.0039
671 UNRESPONSIVE TO STIMULI 101 0.0039
672 DRUG ADMINISTRATION ERROR 120 0.0039
673 SALIVARY HYPERSECRETION 39 0.0039
674 VISUAL IMPAIRMENT 483 0.0039
675 SKIN DISCOLOURATION 179 0.0039
676 LOSS OF CONSCIOUSNESS 499 0.0039
677 DEPRESSED LEVEL OF CONSCIOUSNESS 154 0.0039
678 LYMPHOMA 60 0.0039
679 STAPHYLOCOCCAL INFECTION 128 0.0039
680 BEDRIDDEN 51 0.0039
681 HERNIA 75 0.0039
682 TEMPERATURE INTOLERANCE 40 0.0039
683 STEVENS-JOHNSON SYNDROME 86 0.0039
684 HYPERTHYROIDISM 56 0.0039
685 INJECTION SITE MASS 143 0.0039
686 FATIGUE 3005 0.0039
687 COLITIS 146 0.0038
688 MULTIPLE ORGAN DYSFUNCTION SYNDROME 109 0.0038
689 RASH PAPULAR 86 0.0038
690 THROMBOCYTOPENIA 429 0.0038
691 HYPOXIA 135 0.0038
692 SKIN LESION 105 0.0038
693 PRESCRIBED OVERDOSE 74 0.0038
694 FACE OEDEMA 64 0.0038
695 MASS 53 0.0038
696 DISTURBANCE IN ATTENTION 204 0.0038
697 HALLUCINATION 284 0.0038
698 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 181 0.0038
699 RASH 1634 0.0037
700 FEELING COLD 104 0.0037
701 JOINT RANGE OF MOTION DECREASED 50 0.0037
702 ANOREXIA 48 0.0037
703 EYE INFECTION 42 0.0037
704 SKIN DISORDER 124 0.0037
705 HYPOAESTHESIA ORAL 56 0.0037
706 DEPRESSION 845 0.0037
707 NEUROLEPTIC MALIGNANT SYNDROME 44 0.0037
708 ENCEPHALOPATHY 91 0.0037
709 HAEMOPTYSIS 103 0.0037
710 BACK INJURY 40 0.0037
711 FULL BLOOD COUNT DECREASED 74 0.0037
712 MOBILITY DECREASED 263 0.0037
713 TREMOR 607 0.0037
714 SLEEP DISORDER 258 0.0037
715 POST PROCEDURAL COMPLICATION 70 0.0036
716 LIMB INJURY 99 0.0036
717 TOOTH DISORDER 81 0.0036
718 ABASIA 90 0.0036
719 IMMUNE SYSTEM DISORDER 48 0.0036
720 NERVOUSNESS 190 0.0036
721 DYSSTASIA 106 0.0036
722 PRESYNCOPE 88 0.0036
723 SURGERY 211 0.0036
724 INTENTIONAL PRODUCT MISUSE 315 0.0036
725 NERVE INJURY 40 0.0036
726 BLOOD LACTATE DEHYDROGENASE INCREASED 57 0.0036
727 HAIR TEXTURE ABNORMAL 48 0.0036
728 LIMB DISCOMFORT 111 0.0036
729 ROAD TRAFFIC ACCIDENT 150 0.0036
730 DERMATITIS ALLERGIC 45 0.0036
731 PRURITUS 1374 0.0036
732 DYSPHONIA 209 0.0036
733 SPINAL OPERATION 44 0.0036
734 NECK PAIN 199 0.0036
735 GAIT INABILITY 119 0.0036
736 SCHIZOPHRENIA 43 0.0035
737 EAR INFECTION 94 0.0035
738 PRODUCT AVAILABILITY ISSUE 80 0.0035
739 VERTIGO 214 0.0035
740 JOINT INJURY 75 0.0035
741 MEMORY IMPAIRMENT 482 0.0035
742 MUSCLE SPASMS 642 0.0035
743 PULMONARY EMBOLISM 332 0.0035
744 BURNING SENSATION 244 0.0035
745 PNEUMOTHORAX 55 0.0035
746 EYE DISORDER 114 0.0035
747 HIP FRACTURE 111 0.0034
748 CANDIDA INFECTION 58 0.0034
749 MUSCULOSKELETAL DISCOMFORT 59 0.0034
750 INSOMNIA 913 0.0034
751 TOXIC EPIDERMAL NECROLYSIS 52 0.0034
752 PARALYSIS 49 0.0034
753 ANAPHYLACTIC SHOCK 88 0.0034
754 HYPOAESTHESIA 509 0.0034
755 SWELLING 318 0.0034
756 HIP ARTHROPLASTY 52 0.0034
757 CYTOKINE RELEASE SYNDROME 68 0.0034
758 FEELING HOT 207 0.0034
759 MIDDLE INSOMNIA 63 0.0034
760 PRODUCT ADMINISTRATION ERROR 68 0.0034
761 ASPARTATE AMINOTRANSFERASE INCREASED 178 0.0033
762 FEELING ABNORMAL 801 0.0033
763 POLYNEUROPATHY 40 0.0033
764 RASH MACULO-PAPULAR 74 0.0033
765 PRODUCT TASTE ABNORMAL 45 0.0033
766 LACRIMATION INCREASED 100 0.0033
767 LETHARGY 190 0.0033
768 DYSGEUSIA 245 0.0033
769 FREQUENT BOWEL MOVEMENTS 89 0.0033
770 ACUTE HEPATIC FAILURE 45 0.0033
771 NEUTROPHIL COUNT DECREASED 134 0.0033
772 INCORRECT PRODUCT STORAGE 43 0.0033
773 MUSCLE TIGHTNESS 53 0.0033
774 INSURANCE ISSUE 50 0.0033
775 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 84 0.0033
776 MOVEMENT DISORDER 104 0.0032
777 CARDIOVASCULAR DISORDER 82 0.0032
778 EYE PRURITUS 108 0.0032
779 SOMNOLENCE 644 0.0032
780 ACCIDENTAL OVERDOSE 117 0.0032
781 PERITONITIS 66 0.0032
782 LABORATORY TEST ABNORMAL 94 0.0032
783 ARTHROPATHY 177 0.0032
784 CHILLS 373 0.0032
785 MYELODYSPLASTIC SYNDROME 46 0.0032
786 EYE PAIN 179 0.0032
787 CONTRAINDICATED PRODUCT ADMINISTERED 96 0.0032
788 PAIN 1947 0.0032
789 FIBROMYALGIA 77 0.0032
790 PNEUMONITIS 86 0.0032
791 URTICARIA 528 0.0031
792 IMPAIRED HEALING 103 0.0031
793 FEBRILE NEUTROPENIA 207 0.0031
794 THERAPEUTIC RESPONSE UNEXPECTED 140 0.0031
795 ACUTE RESPIRATORY DISTRESS SYNDROME 55 0.0031
796 ACUTE MYELOID LEUKAEMIA 48 0.0031
797 PARAESTHESIA 483 0.0031
798 HYPOACUSIS 132 0.0031
799 PRESCRIBED UNDERDOSE 61 0.0031
800 JOINT STIFFNESS 80 0.0030
801 BLINDNESS UNILATERAL 43 0.0030
802 SPINAL FRACTURE 61 0.0030
803 INJECTION SITE HAEMORRHAGE 243 0.0030
804 HOT FLUSH 229 0.0030
805 TOOTHACHE 55 0.0030
806 EAR PAIN 59 0.0030
807 LUNG INFECTION 47 0.0030
808 THROMBOSIS 243 0.0030
809 SPEECH DISORDER 158 0.0030
810 DERMATITIS 63 0.0030
811 ELECTROCARDIOGRAM QT PROLONGED 108 0.0030
812 STOMATITIS 182 0.0030
813 MOUTH ULCERATION 63 0.0030
814 ALOPECIA 585 0.0030
815 INFECTION 429 0.0030
816 FLUSHING 301 0.0030
817 LEUKOPENIA 148 0.0030
818 MUSCULOSKELETAL STIFFNESS 259 0.0030
819 RETCHING 63 0.0030
820 BASAL CELL CARCINOMA 46 0.0029
821 DRUG EFFECT INCOMPLETE 107 0.0029
822 THROAT IRRITATION 132 0.0029
823 HEAD DISCOMFORT 52 0.0029
824 TRANSAMINASES INCREASED 65 0.0029
825 CHOKING 57 0.0029
826 NEURALGIA 71 0.0029
827 CLOSTRIDIUM DIFFICILE INFECTION 63 0.0029
828 INFUSION RELATED REACTION 191 0.0029
829 APATHY 42 0.0029
830 HAEMORRHAGE INTRACRANIAL 43 0.0029
831 PRODUCT PHYSICAL ISSUE 58 0.0029
832 DRY EYE 143 0.0029
833 RESPIRATORY DISTRESS 79 0.0029
834 DEVICE RELATED INFECTION 44 0.0029
835 GINGIVAL BLEEDING 39 0.0029
836 DISCOMFORT 174 0.0028
837 PRODUCT PRESCRIBING ISSUE 62 0.0028
838 DEVICE OCCLUSION 40 0.0028
839 WHITE BLOOD CELL COUNT DECREASED 308 0.0028
840 UNDERDOSE 207 0.0028
841 DEAFNESS 74 0.0028
842 INTENTIONAL PRODUCT USE ISSUE 247 0.0028
843 NEOPLASM MALIGNANT 188 0.0028
844 CONDITION AGGRAVATED 856 0.0028
845 ILL-DEFINED DISORDER 171 0.0028
846 COMA 134 0.0028
847 MENTAL IMPAIRMENT 68 0.0028
848 BONE MARROW FAILURE 57 0.0028
849 SCAR 48 0.0028
850 BONE PAIN 164 0.0028
851 SKIN CANCER 60 0.0028
852 THERAPY CESSATION 143 0.0028
853 LUNG NEOPLASM MALIGNANT 114 0.0028
854 DELUSION 43 0.0028
855 ABNORMAL DREAMS 76 0.0027
856 IMMUNODEFICIENCY 41 0.0027
857 DRUG DISPENSING ERROR 42 0.0027
858 ANHEDONIA 72 0.0027
859 HYPERSOMNIA 78 0.0027
860 PAIN IN JAW 77 0.0027
861 INFLAMMATION 140 0.0027
862 DRUG INEFFECTIVE 3575 0.0027
863 HYPERSENSITIVITY 503 0.0027
864 RASH ERYTHEMATOUS 129 0.0027
865 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 190 0.0027
866 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 481 0.0027
867 FEMUR FRACTURE 82 0.0026
868 EXPIRED PRODUCT ADMINISTERED 88 0.0026
869 ERYTHEMA 541 0.0026
870 MUSCULOSKELETAL DISORDER 50 0.0026
871 BACTERIAL INFECTION 49 0.0026
872 THERAPEUTIC RESPONSE DECREASED 159 0.0026
873 VIRAL INFECTION 87 0.0026
874 RASH MACULAR 91 0.0026
875 FEAR 70 0.0026
876 LOWER LIMB FRACTURE 50 0.0026
877 DEATH 2218 0.0026
878 HALLUCINATION, VISUAL 54 0.0026
879 CYANOSIS 40 0.0025
880 ILLNESS 262 0.0025
881 PRODUCT DISPENSING ERROR 55 0.0025
882 ACTIVITIES OF DAILY LIVING IMPAIRED 50 0.0025
883 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 510 0.0025
884 LIVER FUNCTION TEST INCREASED 54 0.0025
885 NEEDLE ISSUE 73 0.0025
886 DRUG INTOLERANCE 241 0.0025
887 CRYING 90 0.0025
888 COVID-19 434 0.0025
889 INTENTIONAL DOSE OMISSION 70 0.0025
890 INJECTION SITE PRURITUS 163 0.0024
891 CONJUNCTIVITIS 45 0.0024
892 MOOD ALTERED 66 0.0024
893 MALIGNANT NEOPLASM PROGRESSION 247 0.0024
894 INCORRECT DOSE ADMINISTERED 545 0.0024
895 NEUTROPENIA 323 0.0024
896 NIGHTMARE 82 0.0024
897 GASTRIC CANCER 60 0.0024
898 GLOSSODYNIA 53 0.0024
899 DYSKINESIA 95 0.0023
900 RESTLESSNESS 85 0.0023
901 INJECTION SITE BRUISING 185 0.0023
902 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 54 0.0023
903 ORAL HERPES 45 0.0023
904 ADVERSE DRUG REACTION 206 0.0023
905 LOWER RESPIRATORY TRACT INFECTION 103 0.0023
906 DISEASE PROGRESSION 267 0.0023
907 THROAT TIGHTNESS 61 0.0023
908 MENTAL DISORDER 98 0.0022
909 HEPATIC CANCER 54 0.0022
910 PRODUCT QUALITY ISSUE 301 0.0022
911 PLASMA CELL MYELOMA 85 0.0022
912 EXTRAPYRAMIDAL DISORDER 53 0.0021
913 TOXICITY TO VARIOUS AGENTS 358 0.0021
914 LIVER INJURY 52 0.0021
915 PANIC ATTACK 77 0.0021
916 OSTEONECROSIS OF JAW 52 0.0021
917 SKIN FISSURES 41 0.0021
918 INJECTION SITE PAIN 640 0.0021
919 ANAPHYLACTIC REACTION 115 0.0021
920 IRRITABILITY 125 0.0021
921 AGGRESSION 104 0.0021
922 ABNORMAL BEHAVIOUR 82 0.0021
923 DRY SKIN 275 0.0021
924 INTENTIONAL OVERDOSE 132 0.0021
925 THERAPY NON-RESPONDER 92 0.0020
926 HAEMORRHAGE 212 0.0020
927 HOSPITALISATION 309 0.0020
928 OFF LABEL USE 1759 0.0020
929 OCULAR HYPERAEMIA 95 0.0020
930 RESPIRATORY ARREST 55 0.0020
931 INCORRECT DRUG ADMINISTRATION DURATION 56 0.0020
932 INJECTION SITE SWELLING 152 0.0020
933 MIGRAINE 189 0.0020
934 EPILEPSY 60 0.0020
935 ECZEMA 102 0.0019
936 COMPLETED SUICIDE 162 0.0019
937 SEIZURE 223 0.0019
938 PSYCHOTIC DISORDER 57 0.0019
939 EMOTIONAL DISORDER 59 0.0019
940 BODY TEMPERATURE INCREASED 39 0.0019
941 AGITATION 140 0.0019
942 NEOPLASM PROGRESSION 66 0.0019
943 UNEVALUABLE EVENT 140 0.0018
944 OVERDOSE 396 0.0018
945 NERVOUS SYSTEM DISORDER 55 0.0018
946 PSORIATIC ARTHROPATHY 69 0.0017
947 PROSTATE CANCER 135 0.0017
948 INJECTION SITE URTICARIA 41 0.0017
949 THERAPEUTIC RESPONSE SHORTENED 55 0.0017
950 INCORRECT DOSE ADMINISTERED BY DEVICE 43 0.0016
951 EYE IRRITATION 93 0.0016
952 PRODUCT SUBSTITUTION ISSUE 93 0.0016
953 THERAPY INTERRUPTED 115 0.0016
954 EXTRA DOSE ADMINISTERED 65 0.0016
955 INJURY 112 0.0016
956 MUCOSAL INFLAMMATION 41 0.0016
957 COLITIS ULCERATIVE 69 0.0015
958 MOOD SWINGS 49 0.0015
959 INJECTION SITE RASH 47 0.0015
960 PROCEDURAL PAIN 42 0.0015
961 DEVICE MALFUNCTION 106 0.0015
962 SUICIDAL IDEATION 136 0.0015
963 ANGER 50 0.0015
964 DEVICE LEAKAGE 63 0.0015
965 PRODUCT DOSE OMISSION IN ERROR 41 0.0014
966 PRODUCT USE IN UNAPPROVED INDICATION 356 0.0014
967 DRUG EFFECT DECREASED 77 0.0014
968 EMOTIONAL DISTRESS 173 0.0014
969 DEVICE ISSUE 128 0.0014
970 BONE DENSITY DECREASED 44 0.0014
971 INJECTION SITE ERYTHEMA 174 0.0014
972 SKIN IRRITATION 64 0.0014
973 CONVULSION 79 0.0014
974 GYNAECOMASTIA 42 0.0014
975 SUICIDE ATTEMPT 77 0.0013
976 BREAST CANCER 118 0.0013
977 DISEASE RECURRENCE 60 0.0013
978 THERAPEUTIC PRODUCT EFFECT DECREASED 56 0.0012
979 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 55 0.0012
980 ACNE 87 0.0011
981 INJECTION SITE REACTION 77 0.0011
982 RENAL CANCER 53 0.0011
983 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 61 0.0011
984 PRODUCT STORAGE ERROR 93 0.0011
985 TREATMENT FAILURE 88 0.0011
986 VAGINAL HAEMORRHAGE 44 0.0010
987 SKIN BURNING SENSATION 70 0.0010
988 MULTIPLE SCLEROSIS RELAPSE 56 0.0008
989 DERMATITIS ATOPIC 41 0.0008
990 DRUG WITHDRAWAL SYNDROME 52 0.0006
991 ACCIDENTAL EXPOSURE TO PRODUCT 57 0.0006
992 MATERNAL EXPOSURE DURING PREGNANCY 45 0.0005
993 DRUG ABUSE 42 0.0005